“Evaluation of Interleukin-35 in Patients with Type 2 Diabetes Mellitus and Its Association with Oxidative Stress and Metabolic Parameters”, CAJMNS, vol. 7, no. 4, pp. 234–241, Aug. 2026, doi: 10.51699/cajmns.v7i4.3369.